Metropolitan Life Insurance Company (MetLife)’s VivoSim Labs VIVS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-232	Closed	-$124K	–	2527
2017 Q3	$124K	Sell	232 -53	-19%	-$28.2K	﹤0.01%	2396
2017 Q2	$180K	Hold	285	–	–	﹤0.01%	2400
2017 Q1	$218K	Buy	285 +37	+15%	+$29.3K	﹤0.01%	2215
2016 Q4	$202K	Sell	248 -29	-10%	-$23K	﹤0.01%	2347
2016 Q3	$252K	Sell	277 -12	-4%	-$11.7K	﹤0.01%	2191
2016 Q2	$258K	Hold	289	–	–	﹤0.01%	2143
2016 Q1	$150K	Buy	289 +8	+3%	+$4.07K	﹤0.01%	2344
2015 Q4	$168K	Buy	281 +1	+0.4%	+$725	﹤0.01%	2368
2015 Q3	$180K	Buy	280 +184	+192%	+$140K	﹤0.01%	2356
2015 Q2	$87K	Buy	+96	New	+$107K	﹤0.01%	2621
2015 Q1	–	Sell	-248	Closed	-$431K	–	2465
2014 Q4	$431K	Hold	248	–	–	﹤0.01%	1864
2014 Q3	$379K	Hold	248	–	–	﹤0.01%	1904
2014 Q2	$496K	Buy	+248	New	+$416K	﹤0.01%	1830

Other funds holding VIVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s VIVS Position: Q4 2017 in Review

Metropolitan Life Insurance Company (MetLife) sold out of VivoSim Labs (VIVS) in Q4 2017, closing a stake of 232 shares — an estimated $124K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VIVS in Q2 2014 and held it in 13 quarters. The position peaked at $496K in Q2 2014. 123 funds tracked by Wall St. Rank hold VIVS as of Q4 2017.

Metropolitan Life Insurance Company (MetLife) reported no remaining VivoSim Labs position as of Q4 2017 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 232 VivoSim Labs shares in Q4 2017, an estimated $124K.
Metropolitan Life Insurance Company (MetLife) first reported a position in VivoSim Labs in Q2 2014 and held it in 13 quarters.
Metropolitan Life Insurance Company (MetLife)'s VivoSim Labs position peaked at $496K in Q2 2014.
123 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2017.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2017, filed 15 Feb 2018.